The 8 analysts offering 12-month price forecasts for Gossamer Bio Inc have a median target of 21.50, with a high estimate of 29.00 and a low estimate of 12.00. The median estimate represents a +109.35% increase from the last price of 10.27.
The current consensus among 8 polled investment analysts is to Buy stock in Gossamer Bio Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.79
Reporting Date Mar 19
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.